Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Palifermin for Oral Mucositis in Sarcoma Patients
NCT00267046Phase 2Completed
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Dec 2005
- Primary completion
- Jul 2009
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of palifermin in oral mucositis (OM), sponsored by University of Texas MD Anderson Cancer Center. Started Dec 2005; status: completed.
02
Drugs
palifermin
03
Conditions
oral mucositis (OM)
Beyond the preview
Go deeper on NCT00267046.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00267046.